Chemoinformaics analysis of Quercetin-3-Alpha-L-Arabinopyranoside
| Molecular Weight | 434.353 | nRot | 3 |
| Heavy Atom Molecular Weight | 416.209 | nRig | 24 |
| Exact Molecular Weight | 434.085 | nRing | 4 |
| Solubility: LogS | -4.028 | nHRing | 2 |
| Solubility: LogP | 0.382 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 17 |
| nHA | 11 | APOL | 54.2243 |
| nHD | 7 | BPOL | 24.1337 |
| QED | 0.277 |
| Synth | 3.931 |
| Natural Product Likeliness | 2.042 |
| NR-PPAR-gamma | 0.948 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.642 |
| HIA | 0.661 |
| CACO-2 | -6.164 |
| MDCK | 0.00000543 |
| BBB | 0.025 |
| PPB | 0.892678 |
| VDSS | 0.875 |
| FU | 0.126139 |
| CYP1A2-inh | 0.118 |
| CYP1A2-sub | 0.048 |
| CYP2c19-inh | 0.021 |
| CYP2c19-sub | 0.046 |
| CYP2c9-inh | 0.044 |
| CYP2c9-sub | 0.347 |
| CYP2d6-inh | 0.11 |
| CYP2d6-sub | 0.18 |
| CYP3a4-inh | 0.081 |
| CYP3a4-sub | 0.013 |
| CL | 5.229 |
| T12 | 0.825 |
| hERG | 0.018 |
| Ames | 0.836 |
| ROA | 0.066 |
| SkinSen | 0.316 |
| Carcinogencity | 0.059 |
| EI | 0.333 |
| Respiratory | 0.03 |
| NR-Aromatase | 0.894 |
| Antiviral | Yes |
| Prediction | 0.853929 |